Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 10/14/2017 |
| Start Date: | November 2012 |
| End Date: | March 2013 |
Pain Control in Bariatric Patients: A Prospective Trial Comparing the Effectiveness of EXPAREL(R) Versus the On-Q(R) Pain Ball
This study was conducted to compare the effectiveness of two local pain control methods in
bariatric patients by assessing the amount of postoperative pain and amount of postoperative
pain medications needed. This information was used to determine which local anesthetic
provided the best pain control.
bariatric patients by assessing the amount of postoperative pain and amount of postoperative
pain medications needed. This information was used to determine which local anesthetic
provided the best pain control.
The investigators have previously utilized the On-Q® pain ball to obtain local control by
continuous delivery of bupivacaine to pain fibers at the incision site. On-Q makes use of an
implanted catheter and a continuous infusion pump that the patient carries with them
typically for 48-72 hours after surgery. EXPAREL is a long-acting liposomal delivery vehicle
that extends the life of bupivacaine in the surgical site for up to 72 hours. It can be
injected in all trocar sites and offers another potential solution to patient pain control
without the need for a catheter and the hardware needed to deliver the local anesthetic.
Patient NRS (numerical rating scale) scores for postoperative pain and total medication
consumed were used to assess the differences between the two treatment groups.
continuous delivery of bupivacaine to pain fibers at the incision site. On-Q makes use of an
implanted catheter and a continuous infusion pump that the patient carries with them
typically for 48-72 hours after surgery. EXPAREL is a long-acting liposomal delivery vehicle
that extends the life of bupivacaine in the surgical site for up to 72 hours. It can be
injected in all trocar sites and offers another potential solution to patient pain control
without the need for a catheter and the hardware needed to deliver the local anesthetic.
Patient NRS (numerical rating scale) scores for postoperative pain and total medication
consumed were used to assess the differences between the two treatment groups.
Inclusion Criteria:
- Age 18-80, male or female
Exclusion Criteria:
- Pregnant women
We found this trial at
1
site
Click here to add this to my saved trials
